ホームページ Transmembrane Transporters ATP7B

ATP7B

ATP7B製品

  • All (1)
  • ATP7Bモジュレータ(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
E1166 Tetrathiomolybdate (TM) Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
Phytomedicine, 2025, 143:156883
J Exp Clin Cancer Res, 2024, 43(1):68
Cell Death Dis, 2024, 15(2):149
E1166 Tetrathiomolybdate (TM) Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
Phytomedicine, 2025, 143:156883
J Exp Clin Cancer Res, 2024, 43(1):68
Cell Death Dis, 2024, 15(2):149
united states